Driving innovation in addiction treatment: role of transcranial magnetic stimulation Graziella MadeoAntonello Bonci Psychiatry and Preclinical Psychiatric Studies - Short Communication 17 January 2024 Pages: 505 - 508
Parkinson’s disease motor progression in relation to the timing of REM sleep behavior disorder presentation: an exploratory retrospective study Roberta BovenziMariangela PierantozziClaudio Liguori Neurology and Preclinical Neurological Studies - Original Article Open access 16 January 2024 Pages: 239 - 244
Current perspectives on brain circuits involved in food addiction-like behaviors Esra SenolHasan Mohammad Psychiatry and Preclinical Psychiatric Studies - Review Article 12 January 2024 Pages: 475 - 485
Morphometric alterations of the mesocorticolimbic network in Parkinson’s disease with impulse control disorders Mohammed Farhan AnsariShweta PrasadPramod Kumar Pal Neurology and Preclinical Neurological Studies - Original Article 12 January 2024 Pages: 229 - 237
The enigma of depression in corticobasal degeneration, a frequent but poorly understood co-morbidity Kurt A. Jellinger Neurology and Preclinical Neurological Studies - Review Article 12 January 2024 Pages: 195 - 202
Facial emotion recognition deficits are associated with hypomimia and related brain correlates in Parkinson’s disease Jon Rodríguez-AntigüedadSaül Martínez-HortaJaime Kulisevsky Neurology and Preclinical Neurological Studies - Original Article 11 January 2024
Psychometric properties of the Caregiver’s inventory neuropsychological diagnosis dementia (CINDD) in mild cognitive impairment and dementia Sofia CuocoCarlo BlundoMarina Picillo Neurology and Preclinical Neurological Studies - Original Article Open access 10 January 2024 Pages: 173 - 180
Sexual dysfunction in men with young onset Parkinson's disease M. SandeepShyam SundarRavi Yadav Neurology and Preclinical Neurological Studies - Original Article 10 January 2024 Pages: 149 - 155
Toxic interactions between dopamine, α-synuclein, monoamine oxidase, and genes in mitochondria of Parkinson’s disease Makoto NaoiWakako MaruyamaPeter Riederer Neurology and Preclinical Neurological Studies - Review Article 09 January 2024
Old problems, new solutions: harnessing technology and innovation in Parkinson’s disease—evidence and experiences from Thailand Roongroj Bhidayasiri Neurology and Preclinical Neurological Studies - Original Article 08 January 2024
Advanced is advanced is advanced is advanced Wolfgang H. Jost Neurology and Preclinical Neurological Studies - Editorial 06 January 2024
Clinical correlates of pareidolias and color discrimination deficits in idiopathic REM sleep behavior disorder and Parkinson’s disease Seoyeon KimJi-Hyun ChoiJee-Young Lee Neurology and Preclinical Neurological Studies - Original Article 18 December 2023 Pages: 141 - 148
Motor cortex transcranial direct current stimulation improves non-motor symptoms in early-onset Parkinson’s disease: a pilot study Clara SimonettaJacopo BissaccoTommaso Schirinzi Neurology and Preclinical Neurological Studies - Original Article 17 December 2023 Pages: 189 - 193
Rewiring the future: drugs abused in adolescence may predispose to mental illness in adult life by altering dopamine axon growth Radu Gabriel AvramescuGiovanni HernandezCecilia Flores Psychiatry and Preclinical Psychiatric Studies - Review Article Open access 01 December 2023 Pages: 461 - 467
Neurogenic orthostatic hypotension in Parkinson’s disease: is there a role for locus coeruleus magnetic resonance imaging? Giovanni PalermoAlessandro GalganiFilippo Sean Giorgi Neurology and Preclinical Neurological Studies - Original Article Open access 30 November 2023 Pages: 157 - 164
Therapeutic use of medical Cannabis in neurological diseases: a clinical update Ute HiddingTina MainkaCarsten Buhmann Neurology and Preclinical Neurological Studies - Review Article Open access 28 November 2023 Pages: 117 - 126
Abstracts of the WASAD Congress 2023: an International Congress of the World Association for Stress Related and Anxiety Disorders, held on 11–13 September 2023 in Zurich, Switzerland Abstracts 23 November 2023 Pages: 1609 - 1639
Psychotherapies in opioid use disorder: toward a step-care model Amaury DurpoixJulie RollingLaurence Lalanne Psychiatry and Preclinical Psychiatric Studies - Original Article Open access 21 November 2023 Pages: 437 - 452
Neuroscience in addiction research Rita J. ValentinoSunila G. NairNora D. Volkow Psychiatry and Preclinical Psychiatric Studies - Short Communication 10 November 2023 Pages: 453 - 459
Levodopa may modulate specific speech impairment in Parkinson's disease: an fMRI study Martina MračkováRadek MarečekIrena Rektorová Neurology and Preclinical Neurological Studies - Original Article 09 November 2023 Pages: 181 - 187
Astrocytic transcriptional and epigenetic mechanisms of drug addiction Leanne M. HoltEric J. Nestler Psychiatry and Preclinical Psychiatric Studies - Review Article 08 November 2023 Pages: 409 - 424
Should continuous dopaminergic stimulation be a standard of care in advanced Parkinson’s disease? Z. PirtošekV. LetaM. Vérin Neurology and Preclinical Neurological Studies - Review Article 06 November 2023 Pages: 1395 - 1404
Baseline prevalence and longitudinal assessment of autonomic dysfunction in early Parkinson’s disease Lanqing YangHuan GaoMin Ye Neurology and Preclinical Neurological Studies - Original Article 04 November 2023 Pages: 127 - 139
Understanding depression with amyotrophic lateral sclerosis: a short assessment of facts and perceptions Kurt A. Jellinger Neurology and Preclinical Neurological Studies - Review Article 03 November 2023 Pages: 107 - 115
The importance of choice and agency in animal models of addiction Serge H. Ahmed Psychiatry and Preclinical Psychiatric Studies - Review Article 31 October 2023 Pages: 487 - 489
Risk of Parkinson’s disease in hepatitis B and C populations: a systematic review and meta-analysis Clyve Yu Leon YaowAshley Shuen Ying HongEng-King Tan Neurology and Preclinical Neurological Studies - Review Article 29 October 2023
Constipation and pain in Parkinson’s disease: a clinical analysis Mohammad Al-WardatPiergiorgio GrilloSilvia Natoli Neurology and Preclinical Neurological Studies - Original Article Open access 28 October 2023 Pages: 165 - 172
Home initiation of apomorphine infusion: lessons from the COVID-19 pandemic and implications for current clinical practice Christopher KobyleckiLucy Partington-Smith Neurology and Preclinical Neurological Studies - Original Article Open access 23 October 2023 Pages: 1485 - 1489
The role of immune and inflammatory-related indicators in cognitive dysfunction and disease severity in patients with parkinson’s disease Xudong ZhaoLei LiWeifeng Luo Neurology and Preclinical Neurological Studies - Original Article 20 October 2023 Pages: 13 - 24
The specific NQO2 inhibitor, S29434, only marginally improves the survival of dopamine neurons in MPTP-intoxicated mice Maeva VallucciJean A. BoutinEtienne C. Hirsch Neurology and Preclinical Neurological Studies - Original Article 18 October 2023 Pages: 1 - 11
Botulinum toxin and conservative treatment strategies in people with cervical dystonia: an online survey Melani J. BoyceA. B. McCambridgeA. P. Verhagen Neurology and Preclinical Neurological Studies - Original Article Open access 13 October 2023 Pages: 43 - 51
Deep brain stimulation for psychostimulant use disorders Sarah E. Swinford-JacksonR. Christopher Pierce Psychiatry and Preclinical Psychiatric Studies - Review Article 12 October 2023 Pages: 469 - 473
Facial emotion expressivity in patients with Parkinson’s and Alzheimer’s disease Antonio CannavacciuoloGiulia PaparellaMatteo Bologna Neurology and Preclinical Neurological Studies - Original Article Open access 07 October 2023 Pages: 31 - 41
Autophagy markers, cognitive deficits and depressive symptoms in Parkinson’s disease Yanzhe LiHechao YangJie Li Psychiatry and Preclinical Psychiatric Studies - Original Article 06 October 2023 Pages: 73 - 81
A 12-month prospective real-life study of opicapone efficacy and tolerability in Emirati and non-White subjects with Parkinson’s disease based in United Arab Emirates Vinod MettaHuzaifa IbrahimK. Ray Chaudhuri Neurology and Preclinical Neurological Studies - Original Article Open access 05 October 2023 Pages: 25 - 30
L-DOPA-therapy in Parkinson’s disease: some personal reflections on L-DOPA therapy from Vienna and Berlin Peter RiedererReinhard Horowski Neurology and Preclinical Neurological Studies - Review Article Open access 05 October 2023 Pages: 1323 - 1335
Nicotinic regulation of microglia: potential contributions to addiction Alexa R. SoaresMarina R. Picciotto Psychiatry and Preclinical Psychiatric Studies - Review Article 01 October 2023 Pages: 425 - 435
The GlyT1-inhibitor Org 24598 facilitates the alcohol deprivation abolishing and dopamine elevating effects of bupropion + varenicline in rats Yasmin OlssonHelga LidöBo Söderpalm Psychiatry and Preclinical Psychiatric Studies - Original Article Open access 29 September 2023 Pages: 95 - 106
Excessive psychological stress preceding the onset of idiopathic cervical dystonia Dirk DresslerBruno KoppFereshte Adib Saberi Psychiatry and Preclinical Psychiatric Studies - Original Article Open access 29 September 2023 Pages: 53 - 57
Pharmacological modulation of HIF-1 in the treatment of neuropsychiatric disorders Diksha SharmaHeena KhanThakur Gurjeet Singh Psychiatry and Preclinical Psychiatric Studies - Review Article 22 September 2023 Pages: 1523 - 1535
Parkinson’s disease patients’ perspective on telephone visits during the COVID-19 pandemic Marta MagriçoMiguel SerôdioPaulo Bugalho Neurology and Preclinical Neurological Studies - Original Article 14 September 2023 Pages: 1547 - 1551
Correction to: Role of dopamine agonists in Parkinson's disease therapy D. WoitallaC. BuhmannD. Weise Correction 13 September 2023
Current and novel infusion therapies for patients with Parkinson's disease Angelo AntoniniValentina D’OnofrioAndrea Guerra Neurology and Preclinical Neurological Studies - Review Article Open access 06 September 2023 Pages: 1349 - 1358
Correction: Clinimetrics and feasibility of the Italian version of the Frontal Assessment Battery (FAB) in non-demented Parkinson’s disease patients Edoardo Nicolò AielloAlfonsina D’IorioBarbara Poletti Correction 04 September 2023
Pathomechanisms of cognitive and behavioral impairment in corticobasal degeneration Kurt A. Jellinger Neurology and Preclinical Neurological Studies - Review Article 02 September 2023 Pages: 1509 - 1522
Practical use of apomorphine infusion in Parkinson’s disease: lessons from the TOLEDO study and clinical experience Tove HenriksenRegina KatzenschlagerAndrew Lees Neurology and Preclinical Neurological Studies - Original Article Open access 01 September 2023 Pages: 1475 - 1484
A wearable device-enabled therapeutic approach to improve joint attention in autism spectrum disorder: a prospective pilot study Isabelle TahmazianAlexander WattsTaylor Chomiak Psychiatry and Preclinical Psychiatric Studies - Short communication 30 August 2023 Pages: 1601 - 1607
A sporadic Parkinson’s disease model via silencing of the ubiquitin–proteasome/E3 ligase component, SKP1A Tali Fishman-JacobMoussa B. H. Youdim Neurology and Preclinical Neurological Studies - Review Article Open access 29 August 2023
Catecholamines and Parkinson’s disease: tyrosine hydroxylase (TH) over tetrahydrobiopterin (BH4) and GTP cyclohydrolase I (GCH1) to cytokines, neuromelanin, and gene therapy: a historical overview Toshiharu Nagatsu Neurology and Preclinical Neurological Studies - Review Article 28 August 2023
Practice behaviors as trigger factor for the onset of Musicians’ Dystonia Edoardo PassarottoJohanna Doll-LeeAndré Lee Neurology and Preclinical Neurological Studies - Original Article Open access 26 August 2023 Pages: 1561 - 1569
